EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:32090 - rebamipide
| ChEBI ID | CHEBI:32090 |
| ChEBI Name | rebamipide |
| Stars | |
| Definition | A racemate comprising equimolar amounts of (R)- and (S)-rebamipide. It is a drug used for the treatment of gastric ulcers. |
| Last Modified | 14 May 2026 |
| Formula | C19H15ClN2O4 |
| Net Charge | 0 |
| Average Mass | 370.792 |
| Monoisotopic Mass | 370.07203 |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Chemical Role: | radical scavenger A role played by a substance that can react readily with, and thereby eliminate, radicals. |
| Applications: | anti-inflammatory agent Any compound that has anti-inflammatory effects. gastrointestinal drug A drug used for its effects on the gastrointestinal system, e.g. controlling gastric acidity, regulating gastrointestinal motility and water flow, and improving digestion. antirheumatic drug A drug used to treat rheumatoid arthritis. anti-ulcer drug One of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| rebamipide (CHEBI:32090) has part (R)-rebamipide (CHEBI:747740) |
| rebamipide (CHEBI:32090) has part (S)-rebamipide (CHEBI:747741) |
| rebamipide (CHEBI:32090) has role anti-inflammatory agent (CHEBI:67079) |
| rebamipide (CHEBI:32090) has role anti-ulcer drug (CHEBI:49201) |
| rebamipide (CHEBI:32090) has role antineoplastic agent (CHEBI:35610) |
| rebamipide (CHEBI:32090) has role antirheumatic drug (CHEBI:35842) |
| rebamipide (CHEBI:32090) has role gastrointestinal drug (CHEBI:55324) |
| rebamipide (CHEBI:32090) has role ophthalmology drug (CHEBI:66981) |
| rebamipide (CHEBI:32090) has role radical scavenger (CHEBI:48578) |
| rebamipide (CHEBI:32090) is a racemate (CHEBI:60911) |
| IUPAC Name |
|---|
| N-(4-chlorobenzoyl)-3-(2-oxo-1,2-dihydroquinolin-4-yl)-DL-alanine |
| INNs | Source |
|---|---|
| rebamipida | WHO MedNet |
| rebamipide | WHO MedNet |
| rébamipide | WHO MedNet |
| rebamipidum | WHO MedNet |
| Synonyms | Source |
|---|---|
| (2RS)-2-(4-chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid | ChEBI |
| (2RS)-2-(4-chlorobenzoylamino)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propionic acid | ChEBI |
| rac-(2R)-2-(4-chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid | IUPAC |
| rac-rebamipide | ChEBI |
| NSC-758955 | ChEMBL |
| OPC 12759 | ChEBI |
| Brand Names | Source |
|---|---|
| Mucosta | KEGG DRUG |
| Rebagen | ChEBI |
| Rebagit | ChEBI |
| Rebamax | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| 4866 | ChemSpider |
| D01121 | KEGG DRUG |
| DB11656 | DrugBank |
| Rebamipide | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| CAS:90098-04-7 | CAS |
| Citations |
|---|